Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol HLA-B contributors: mct/npt - updated : 19/11/2008
HGNC name major histocompatibility complex, class I, B
HGNC id 4932
Location 6p21.3      Physical location : 2.615.166 - 31.324.989
Synonym name
  • HLA-B,beta chain, 44kDa, class Ia (see MHC1)
  • ankylosing spondylitis
  • MHC class I antigen HLA-B heavy chain
  • HLA class I histocompatibility antigen, B-7 alpha chain
  • lymphocyte antigen
  • HLA class I histocompatibility antigen, Cw-5 alpha chain
  • MHC class I antigen B*
  • Synonym symbol(s) AS, HLA-B-7301, HLA-B73, HLAB, HLAC, SPDA1, Bw*, MGC111087
    DNA
    TYPE functioning gene
    STRUCTURE 3.34 kb     8 Exon(s)
    MAPPING cloned Y linked N status confirmed
    Physical map
    LOC389377 6 similar to KMQK697 C6orf15 6p21.3 chromosome 6 open reading frame 15 PSORS1C1 6p21.3 psoriasis susceptibility 1 candidate 1 CDSN 6p21.3 corneodesmosin PSORS1C2 6p21.3 psoriasis susceptibility 1 candidate 2 C6orf18 6p21.3 chromosome 6 open reading frame 18 TCF19 6p21.3 transcription factor 19 (SC1) POU5F1 6p21.31 POU domain, class 5, transcription factor 1 LOC253018 6p21.32 hypothetical protein LOC253018 LOC391911 6 similar to HLA-B-associated transcript 1A; HLA-B associated transcript 1A; HLA-B associated transcript 1; Nuclear RNA helicase HLA-C 6p21.3 major histocompatibility complex, class I, C HLA-B 6p21.3 major histocompatibility complex, class I, B MICA 6p21.3 MHC class I polypeptide-related sequence A HCP5 6p21.3 HLA complex P5 MICB 6p21.3 MHC class I polypeptide-related sequence B PPIP9 6p21.3 peptidylprolyl isomerase (cyclophilin) pseudogene 9 BAT1 6p21.33 HLA-B associated transcript 1 ATP6V1G2 6p21.3 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G isoform 2 NFKBIL1 6p21.3 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 LTA 6p21.3 lymphotoxin alpha (TNF superfamily, member 1) TNF 6p21.3 tumor necrosis factor (TNF superfamily, member 2) LTB 6p21.3 lymphotoxin beta (TNF superfamily, member 3) LST1 6p21.3 leukocyte specific transcript 1 NCR3 6p21.3 natural cytotoxicity triggering receptor 3 AIF1 6p21.3 allograft inflammatory factor 1 BAT2 6p21.33 HLA-B associated transcript 2 BAT3 6p21.33 HLA-B associated transcript 3 APOM 6p21.31 apolipoprotein M C6orf47 6p21.3 chromosome 6 open reading frame 47 BAT4 6p21.33 HLA-B associated transcript 4 CSNK2B 6p21.3 casein kinase 2, beta polypeptide LY6G5B 6p21.3 lymphocyte antigen 6 complex, locus G5B LY6G5C 6p21.3 lymphocyte antigen 6 complex, locus G5C
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    8 - 1578 38 362 - -
    EXPRESSION
    Type ubiquitous
       expressed in (based on citations)
    organ(s)
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Blood / Hematopoietic    
    cells
    SystemCellPubmedSpeciesStageRna symbol
     mast cell
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • two extracellular globular domains, alpha 1 and alpha 2
  • a transmembranee segment
  • a cytoplasmic tail, highly polymorphic, 118 alleles
  • conjugated GlycoP
    mono polymer heteromer , dimer
    HOMOLOGY
    Homologene
    FAMILY
  • MHC class I family
  • CATEGORY antigen
    SUBCELLULAR LOCALIZATION
    basic FUNCTION
  • play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS immunity/defense
    PATHWAY
    metabolism
    signaling
    a component
  • heterodimer of alpha and beta chain, the alpha 1 domain forming the peptide groove with the beta 1 domain of HLA-DMB
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • releasing the CLIP molecule from the peptide binding site
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Susceptibility
  • ankylosing spondylitis (AS)
  • Behcet's disease
  • to psoriasis arthropathy
  • Variant & Polymorphism other
  • interaction between KIR3DS1 and HLA-B (BW4-80Ile) decreases progression of HIV1
  • HLA-B51 associated to Behcet's disease
  • HLA-B27 associated to ankylosing spondylitis (may arise because of aberrant folding of HLA-B27 molecules within the ER)
  • HLA-B51 may play a role in the pathogenesis of psoriasis arthropathy
  • linkage to the HLA-B region in one AS pedigree (Gu 2009)
  • Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS